This inventor holds 1 USPTO granted patent and 1 published patent application and 1 EPO patent. Top assignee: Adeka Corporation. Active years: 2025.
Company Filing History:
Years Active: 2025
Title: Mitsumasa Homma: Innovator in Decellularized Transplantation Materials
Introduction
Mitsumasa Homma is a prominent inventor based in Tokyo, Japan. He is known for his significant contributions to the field of transplantation materials, particularly through his innovative methods for producing decellularized materials.
Latest Patents
Homma holds a patent for a "Method for producing decellularized material for transplantation and graft composition consisting of biocompatible material including said material." This patent outlines a method that includes several steps: harvesting a branch-bearing blood vessel from a vertebrate animal, decellularizing the blood vessel, and adhering a portion where a branch has been excised to close the vessel through a protein denaturation treatment. The resulting graft composition consists of a biocompatible material that contains the decellularized transplantation material.
Career Highlights
Mitsumasa Homma is associated with Adeka Corporation, where he has been able to apply his expertise in the development of advanced medical materials. His work has the potential to significantly impact the field of transplantation and regenerative medicine.
Collaborations
Homma collaborates with notable colleagues, including Tetsuya Higami and Kenichiro Hiwatari, who contribute to his research and development efforts in the field.
Conclusion
Mitsumasa Homma's innovative work in decellularized transplantation materials showcases his dedication to advancing medical technology. His contributions are paving the way for future developments in the field of regenerative medicine.